ARCHIVES

NKTR-102 Shows 29 Percent Response in Phase II Study

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

NCI, FDA Courting Drug Sponsors To Add Clinical Trials To PDQ Database

October 11, 1996

Avastin For Adjuvant Treatment Of Colon Cancer Showed Benefit At One Year, But Failed Overall

June 5, 2009

DCT Board Okays Six Contract Recompetitions

October 23, 1987

Hybridoma Cell Lines Available from NCI

September 3, 1982

John Durant Names ASCO Executive NP; A New Position, New Voice In Washington

December 2, 1994

NCI Reorganization Proposals Create opposition Among Some Advisors

June 17, 1988